Optinose Stock In The News

OPTN Stock  USD 6.56  0.13  1.94%   
Our overall analysis of OptiNose's news coverage and content from conventional and social sources shows investors' bearish mood towards OptiNose. The specific impact of OptiNose news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of OptiNose's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using OptiNose headlines in addition to utilizing other, more conventional financial analysis modules. Check out OptiNose Backtesting and OptiNose Hype Analysis.
To learn how to invest in OptiNose Stock, please use our How to Invest in OptiNose guide.

OptiNose Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
Optinose Announces Preliminary Unaudited Fourth Quarter 2024 XHANCE Net Revenue of $22.4 Million
https://www.globenewswire.com/news-release/2025/01/15/3009895/0/en/Optinose-Announces-Preliminary-Unaudited-Fourth-Quarter-2024-XHANCE-Net-Revenue-of-22-4-Million.html
 Bullish
Macroaxis News: globenewswire.com
Optinose to Present at the 35th Annual Piper Sandler Healthcare Conference
https://www.globenewswire.com/news-release/2023/11/22/2784826/0/en/Optinose-to-Present-at-the-35th-Annual-Piper-Sandler-Healthcare-Conference.html
 Bullish
Macroaxis News: globenewswire.com
Optinose Reports Third Quarter 2023 Financial Results and Operational Updates
https://www.globenewswire.com/news-release/2023/11/09/2777182/0/en/Optinose-Reports-Third-Quarter-2023-Financial-Results-and-Operational-Updates.html
 Neutral
Macroaxis News: globenewswire.com
Optinose Announces Reporting Date for Third Quarter 2023 Financial Results
https://www.globenewswire.com/news-release/2023/10/27/2768376/0/en/Optinose-Announces-Reporting-Date-for-Third-Quarter-2023-Financial-Results.html
 Bullish
Macroaxis News: globenewswire.com
Optinose to Present at the 2023 Cantor Global Healthcare Conference
https://www.globenewswire.com/news-release/2023/09/22/2747999/0/en/Optinose-to-Present-at-the-2023-Cantor-Global-Healthcare-Conference.html
 Bullish
Macroaxis News: globenewswire.com
Optinose Reports Second Quarter 2023 Financial Results and Operational Updates
https://www.globenewswire.com/news-release/2023/08/10/2722489/0/en/Optinose-Reports-Second-Quarter-2023-Financial-Results-and-Operational-Updates.html
 Bullish
Macroaxis News: globenewswire.com
Optinose Announces Preliminary Second Quarter 2023 XHANCE Net Revenue of $19.5 Million
https://www.globenewswire.com/news-release/2023/07/27/2712025/0/en/Optinose-Announces-Preliminary-Second-Quarter-2023-XHANCE-Net-Revenue-of-19-5-Million.html
 Neutral
Yahoo News
Optinose Announces Preliminary Second Quarter 2023 XHANCE Net Revenue of $19.5 Million
https://finance.yahoo.com/news/optinose-announces-preliminary-second-quarter-110000828.html
 Neutral
Yahoo News
When Will OptiNose, Inc. (NASDAQ:OPTN) Breakeven?
https://finance.yahoo.com/news/optinose-inc-nasdaq-optn-breakeven-122844872.html
 Bullish
Yahoo News
Optinose Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
https://finance.yahoo.com/news/optinose-announces-inducement-grant-under-200800930.html
 Bullish

OptiNose Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide OptiNose and other traded companies coverage with news coverage. We help investors stay connected with OptiNose headlines for the 24th of January to make an informed investment decision based on correlating the impacts of news items on OptiNose Stock performance. Please note that trading solely based on the OptiNose hype is not for everyone as timely availability and quick action are needed to avoid losses.
OptiNose's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help OptiNose investors visualize upcoming and past events in order to time the market based on OptiNose noise-free hype analysis.
OptiNose stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the OptiNose earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about OptiNose that are available to investors today. That information is available publicly through OptiNose media outlets and privately through word of mouth or via OptiNose internal channels. However, regardless of the origin, that massive amount of OptiNose data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of OptiNose news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of OptiNose relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to OptiNose's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive OptiNose alpha.

OptiNose Largest EPS Surprises

Earnings surprises can significantly impact OptiNose's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2023-11-09
2023-09-30-0.09-0.080.0111 
2024-08-08
2024-06-30-0.08-0.050.0337 
2023-05-11
2023-03-31-0.14-0.17-0.0321 
2022-03-08
2021-12-31-0.26-0.230.0311 
2022-05-12
2022-03-31-0.27-0.31-0.0414 
2021-11-15
2021-09-30-0.36-0.320.0411 
View All Earnings Estimates

OptiNose Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to OptiNose Stock. The global stock market is bullish. About 62% of major world exchanges and indexes are currently up. See today's market update for more information.
Gurufocus Stories at Macroaxis
15th of January 2025
Optinose Announces Preliminary Unaudited Fourth Quarter 2024 XHANCE Net Revenue of 22.4 Mi...
at gurufocus.com 
news
27th of December 2024
OptiNose, Inc. Short Interest Update
at thelincolnianonline.com 
bizjournals News
26th of December 2024
Optinose to enact 1-for-15 reverse stock split under threat of Nasdaq delisting
at bizjournals.com 
Yahoo News
10th of December 2024
UNOS CEO Urges Congressional Action on Lifesaving Reforms
at finance.yahoo.com 
Simply Wall St News at Macroaxis
26th of November 2024
OptiNose, Inc. Might Not Be As Mispriced As It Looks After Plunging 31
at simplywall.st 
Yahoo News
15th of November 2024
OptiNose, Inc. Just Reported, And Analysts Assigned A US3.50 Price Target
at finance.yahoo.com 
Gurufocus Stories at Macroaxis
13th of November 2024
FMR LLCs Strategic Acquisition of OptiNose Inc Shares
at gurufocus.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards OptiNose in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, OptiNose's short interest history, or implied volatility extrapolated from OptiNose options trading.
When determining whether OptiNose offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of OptiNose's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Optinose Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Optinose Stock:
Check out OptiNose Backtesting and OptiNose Hype Analysis.
To learn how to invest in OptiNose Stock, please use our How to Invest in OptiNose guide.
You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of OptiNose. If investors know OptiNose will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about OptiNose listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.35)
Revenue Per Share
0.553
Quarterly Revenue Growth
0.031
Return On Assets
(0.10)
Return On Equity
(10.51)
The market value of OptiNose is measured differently than its book value, which is the value of OptiNose that is recorded on the company's balance sheet. Investors also form their own opinion of OptiNose's value that differs from its market value or its book value, called intrinsic value, which is OptiNose's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because OptiNose's market value can be influenced by many factors that don't directly affect OptiNose's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between OptiNose's value and its price as these two are different measures arrived at by different means. Investors typically determine if OptiNose is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OptiNose's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.